| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
| 05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/28/2013 | CA2222455C A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 05/23/2013 | WO2013075068A1 Polymer protein microparticles |
| 05/23/2013 | WO2013075040A1 Cholesterol ester transfer protein (cetp) inhibitor polypeptide antibodies for prophylactic and therapeutic anti-atherosclerosis treatments |
| 05/23/2013 | WO2013074840A1 Treatment of dry age related macular degeneration |
| 05/23/2013 | WO2013074820A1 Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
| 05/23/2013 | WO2013074696A1 Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof |
| 05/23/2013 | WO2013074636A1 Muscle specific receptor kinase and modulation thereof |
| 05/23/2013 | WO2013074557A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a |
| 05/23/2013 | WO2013074501A1 Heterologous prime-boost immunization using measles virus-based vaccines |
| 05/23/2013 | WO2013074492A1 Methods of treating cancer |
| 05/23/2013 | WO2013074489A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | WO2013072542A1 Adjuvant effect of the vaccinia virus a27 protein (14k) and the use thereof in vaccines |
| 05/23/2013 | WO2013072519A1 Vaccine |
| 05/23/2013 | WO2013072518A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation |
| 05/23/2013 | WO2013072514A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | WO2013072513A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
| 05/23/2013 | WO2013072512A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | WO2013072511A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072510A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072415A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | WO2013072406A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | WO2013072051A1 Nanoparticle compositions for generation of regulatory t cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
| 05/23/2013 | WO2013071409A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | WO2013049531A3 Multilayer magnetic micelle compositions and methods for their use |
| 05/23/2013 | WO2013048153A3 Binding molecule having influenza a virus-neutralizing activity produced from human b cell |
| 05/23/2013 | WO2013048130A3 Binding molecule for neutralizing rabies virus |
| 05/23/2013 | WO2013044203A3 Novel influenza hemagglutinin protein-based vaccines |
| 05/23/2013 | WO2013037841A3 Chimeric non-integrating lentiviral genomes as vaccines against hiv-1 |
| 05/23/2013 | WO2013015586A3 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 05/23/2013 | WO2009060305A3 Analogues of glycolipids useful as immunoadjuvants |
| 05/23/2013 | WO2008147883A8 Prevention and treatment of complement-associated eye conditions |
| 05/23/2013 | US20130131125 Therapeutic combination |
| 05/23/2013 | US20130130996 Peptides for inhibiting chemokine binding to chemokine receptors |
| 05/23/2013 | US20130130965 Method to detect and treat infectious or inflammatory diarrhea based on reg1 |
| 05/23/2013 | US20130129790 Adjuvant Incorporation in Immunonanotherapeutics |
| 05/23/2013 | US20130129786 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 05/23/2013 | US20130129783 Use of botulinum neurotoxin to alleviate various disorders |
| 05/23/2013 | US20130129782 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 05/23/2013 | US20130129780 Modified infectious laryngotracheitis virus (iltv) and uses thereof |
| 05/23/2013 | US20130129779 Cattle reproductive disease vaccines |
| 05/23/2013 | US20130129778 Viral particles derived from an enveloped virus |
| 05/23/2013 | US20130129776 Broad Spectrum Vaccine Against Typhoidal and Non-typhoidal Salmonella Disease |
| 05/23/2013 | US20130129770 Influenza vaccine |
| 05/23/2013 | US20130129769 Method for making targeted therapeutic agents directed to soluble targets |
| 05/23/2013 | US20130129768 Treatment or prevention of infection |
| 05/23/2013 | US20130129767 Vaccines against pregnancy-associated malaria |
| 05/23/2013 | US20130129766 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 05/23/2013 | US20130129760 Polypeptides |
| 05/23/2013 | US20130129756 Novel immunoadjuvant compounds and uses thereof |
| 05/23/2013 | US20130129752 Targeted delivery to leukocytes using protein carriers |
| 05/23/2013 | US20130129749 Humanized anti-egfl7 antibodies and methods using same |
| 05/23/2013 | US20130129748 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases |
| 05/23/2013 | US20130129747 Cross-protective pathogen protection, methods and compositions thereof |
| 05/23/2013 | US20130129742 Human leukolectins and uses thereof |
| 05/23/2013 | US20130129740 Nucleic acids and proteins from streptococcus groups a and b |
| 05/23/2013 | US20130129738 Pharmaceutical composition |
| 05/23/2013 | US20130129737 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof |
| 05/23/2013 | US20130129735 Antibodies to egfl7 and methods for their use |
| 05/23/2013 | US20130129734 Composition and methods for the diagnosis, prognosis and treatment of leukemia |
| 05/23/2013 | US20130129733 Humanized anti-egfl7 antibodies and methods using same |
| 05/23/2013 | US20130129732 Method for preserving food |
| 05/23/2013 | US20130129729 Compositions comprising cross-species-specific antibodies and uses thereof |
| 05/23/2013 | US20130129725 Human fgf receptor and beta-klotho binding proteins |
| 05/23/2013 | US20130129722 Methods for Treating Cancer by Administering an Anti-Ang-2 Antibody |
| 05/23/2013 | US20130129720 Combination Cancer Therapies with Wortmannin Analogs |
| 05/23/2013 | US20130129719 Her2 nucleic acid aptamers |
| 05/23/2013 | US20130129718 Purification of anti-c-met antibodies |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129716 System and method for determining compatibility of bioactive agents and formulations provided therefrom |
| 05/23/2013 | US20130129713 Method of antigen loading for immunotherapy |
| 05/23/2013 | US20130129677 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| 05/23/2013 | US20130129676 Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection |
| 05/23/2013 | US20130129621 Integrin Receptor Antagonists and Their Methods of Use |
| 05/23/2013 | US20130129617 Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody |
| 05/23/2013 | CA2856154A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute_condition |
| 05/23/2013 | CA2856150A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | CA2856142A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizingthe circulation |
| 05/23/2013 | CA2856141A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | CA2856136A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | CA2856085A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | CA2855826A1 Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof |
| 05/23/2013 | CA2855822A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a |
| 05/23/2013 | CA2855803A1 Vaccine |
| 05/23/2013 | CA2855797A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation |
| 05/23/2013 | CA2855749A1 Polymer protein microparticles |
| 05/23/2013 | CA2855675A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | CA2850591A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | CA2849196A1 Binding molecules for bcma and cd3 |
| 05/22/2013 | EP2594589A1 ANTI-Trop-2 ANTIBODY |
| 05/22/2013 | EP2594588A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or an anti-ADM non-Ig scaffold for use in therapy |
| 05/22/2013 | EP2594587A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/22/2013 | EP2594586A1 IL-31 monoclonal antibodies and methods of use |
| 05/22/2013 | EP2594582A2 Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens |